The present disclosure concerns methods for recombinantly producing functional ataxia-telangiectasia (ATM) protein, methods for isolating recombinant functional ATM protein, and uses of ATM protein. In particular, a method is disclosed for using a vaccinia virus vector to express ATM, and using immunoprecipitation or affinity tagging to isolate recombinant ATM.

 
Web www.patentalert.com

< Diagnostic sequencing by a combination of specific cleavage and mass spectrometry

< Intracellular amyloid-beta binding (ERAB) polypeptide-related assays

> Method of identifying inhibitors of C—C chemokine receptor 3

> Splice variants of CD40-receptor
~ 00237